EUVIMEDEUVIMED entdecken
Crossref

Serial positron-emission tomography after induction therapy as a predictor of prognostic outcomes for patients with thymic carcinoma

Yudai Miyashita, Takashi Kanou, Tomomi Isono, Hiroto Ishida, Hideki Nagata, Teiko Sakurai, Kenji Kimura, Eriko Fukui, Toru Kimura, Naoko Ose, Tadashi Watabe, Yasushi Shintani

Surgery Today · 2025

DOI: 10.1007/s00595-024-02954-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Yudai Miyashita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-15 Yamada-Oka, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Thymus Neoplasms, Positron Emission Tomography Computed Tomography, Thymoma, Positron-Emission Tomography. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To investigate the role of 18F-fluorodeoxy glucose-positron emission tomography/computed tomography (FDG-PET/CT) to assess pathological response and prognosis after induction therapy in patients with thymic carcinoma. METHODS: The subjects of this retrospective study were 18 patients with thymic carcinoma who underwent FDG-PET, before and after induction therapy. We measured the maximum standardized uptake value (SUVmax) of the tumor and analyzed the correlation between the change in SUVmax and pathological response or recurrence. RESULTS: Induction therapy led to a reduction in both the tumor size and SUVmax in most patients. A strong correlation (Pearson coefficient = 0.90, p 50% predicted lower recurrence rates (p = 0.03). CONCLUSION: Changes in the SUVmax following induction therapy may serve as a valuable predictor of recurrence in patients with thymic carcinoma. This finding highlights the potential of FDG-PET as a tool for patient monitoring and prognostication of this rare subset of carcinomas. Further studies are warranted to validate these results and standardize the FDG-PET protocols for optimal clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thymus NeoplasmsPositron Emission Tomography Computed TomographyThymomaPositron-Emission TomographyInduction ChemotherapyHumansMaleFemalePrognosisMiddle AgedFluorodeoxyglucose F18Retrospective StudiesAgedAdultNeoplasm Recurrence, LocalTreatment OutcomeRadiopharmaceuticalsPredictive Value of TestsAged, 80 and over

Stichwörter der Autor:innen

FDG-PET/CTPathological responseRecurrenceThymic carcinoma

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-15 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
  • Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-15 Yamada-Oka, Suita, Osaka, 565-0871, Japan. kanoutakashi0999@yahoo.co.jp.
  • Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.

Zitieren

APA

Miyashita, Y., Kanou, T., Isono, T., Ishida, H., Nagata, H., Sakurai, T., Kimura, K., Fukui, E., Kimura, T., Ose, N., Watabe, T., & Shintani, Y. (2025). Serial positron-emission tomography after induction therapy as a predictor of prognostic outcomes for patients with thymic carcinoma. Surgery Today. https://doi.org/10.1007/s00595-024-02954-3

Vancouver

Miyashita Y, Kanou T, Isono T, Ishida H, Nagata H, Sakurai T, et al. Serial positron-emission tomography after induction therapy as a predictor of prognostic outcomes for patients with thymic carcinoma. Surgery Today. 2025. doi:10.1007/s00595-024-02954-3

BibTeX
@article{Miyashita2025,
  author = {Miyashita, Yudai and Kanou, Takashi and Isono, Tomomi and Ishida, Hiroto and Nagata, Hideki and Sakurai, Teiko and Kimura, Kenji and Fukui, Eriko and Kimura, Toru and Ose, Naoko and Watabe, Tadashi and Shintani, Yasushi},
  title = {Serial positron-emission tomography after induction therapy as a predictor of prognostic outcomes for patients with thymic carcinoma},
  journal = {Surgery Today},
  year = {2025},
  doi = {10.1007/s00595-024-02954-3}
}
Kostenlos starten →